Humanin Dosage, half-life & reference guide

Also known as HN · Mitochondrial-derived peptide

Another mitochondrial-derived peptide. In cell and rodent studies it protects cells from programmed death, improves insulin sensitivity and lowers the toxicity of amyloid-beta, the protein linked to Alzheimer's.

Studied range
2–4 mg
How often
Weekly
Evidence
●●● Emerging
Route
SubQ injection

Studied in research — not a recommendation.

Humanin dose guide

How it works.

Mitochondria-derived peptide with cytoprotective and neuroprotective effects. In cell and rodent studies (many using the more potent analog HNG) it reduces apoptosis, improves insulin sensitivity and lowers amyloid-beta toxicity. Higher levels were found in children of centenarians, though how it relates to longevity is unclear.

Commonly reported: Subtle or no felt effect, and community reports are sparse. Children of centenarians have higher humanin levels, but it has never been tested as a treatment in people.

Where Humanin works.

A body with Brain, nerves & sleep, Appetite & metabolism and Energy & longevity lit
  • Brain, nerves & sleep

    In animals. Strong animal mechanism work in neuroprotection and insulin sensitivity, much of it with the analog HNG.

  • Appetite & metabolism

    In animals. Its work is background cell protection and better insulin sensitivity, seen so far only in cells and rodents.

  • Energy & longevity

    In animals. Mitochondria-derived peptide with cytoprotective and neuroprotective effects. In cell and rodent studies (many using the more potent analog HNG) it reduces apoptosis.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

Week by week.

What to expect in the first 8 weeks

  1. Day 1–28Animal

    Quiet month — nothing loud happens

    Humanin is a slow, quiet peptide: commonly reported, you won't feel much, if anything, the way you would a GH pulse or a GLP-1 dose. Its work is background cell protection and better insulin sensitivity, seen so far only in cells and rodents.

    The science

    Humanin is a 24-amino acid mitochondrial-derived peptide (MDP). Guo 2003 showed it blocks Bax-driven cell death; Muzumdar 2009 showed it improves insulin sensitivity in rats. Children of centenarians have higher circulating humanin (Yen 2020), though among the oldest people higher levels tracked worse health (Conte 2019): suggestive, not causal.

    Sources
    • Guo et al. (2003)
    • Muzumdar et al. (2009)
    • Yen et al. (2020)
    • Conte et al. (2019)

    Updated Sep 2026

  2. Day 28–56Animal

    Metabolic markers may be shifting

    If you track fasting glucose or HbA1c, it's a reasonable time to check, though the insulin effect has only been seen in rodents and no study sets a timeline. Commonly reported: little to feel; some describe steadier energy.

    The science

    In rats, humanin improved insulin sensitivity in clamp studies, acting through the brain via hypothalamic STAT-3 signaling (Muzumdar 2009); no study gives a 4–6 week window. Humanin also binds IGFBP-3, which matters for cell survival (Ikonen 2003). No completed human trials for metabolic endpoints.

    Sources
    • Muzumdar et al. (2009)
    • Ikonen et al. (2003)

    Updated Sep 2026

  3. Day 56–84Community

    Good point to reassess

    Community protocols commonly run 8–12 weeks — less a stopping point than a reassessment prompt, since long-term human data doesn't exist. If something meaningful shifted (energy, recovery, metabolic markers), a pause here lets you see what sticks. If nothing named itself, another cycle probably won't change that.

    The science

    Long-term human dosing data is essentially nonexistent. The cycle convention is conservative — Humanin interacts with apoptotic signaling, and chronic exogenous supraphysiological exposure hasn't been characterized in humans.

    Sources
    • Yen et al. (2013)

    Updated Apr 2026

  4. Any dayAnimal

    What Humanin is built on

    Humanin has mixed correlational data in human longevity studies and strong animal mechanism work in neuroprotection and insulin sensitivity, much of it with the analog HNG. It has never been given to people in a study.

    The science

    Discovered by Hashimoto et al. 2001 in the context of Alzheimer's research — Humanin was identified as a peptide that protected neurons from amyloid-beta toxicity. Since then, its role as a mitochondrial-derived peptide regulating metabolism has broadened the interest. No phase 2 or 3 trials have completed for any indication.

    Sources
    • Hashimoto et al. (2001)
    • Muzumdar et al. (2009)

    Updated Sep 2026

  5. With MOTS-c and SS-31Community

    The mitochondrial-peptide trio

    MOTS-c, humanin and SS-31 work on three different angles of mitochondrial health — metabolic signaling, cell-death regulation and membrane integrity. No study has combined them; it's a popular longevity stack on that logic.

    The science

    MOTS-c activates AMPK for metabolic signaling; Humanin antagonizes Bax-mediated cell death; SS-31 binds cardiolipin to stabilize the inner mitochondrial membrane. No combination study in any species, but the three target distinct mitochondrial compartments without obvious redundancy.

    Sources
    • Lee et al. (2015)

    Updated Sep 2026

Day 1 is the day you start it.

Mixing and a typical run.

Example numbers

Reconstitution example

Reconstitute a 10 mg vial of Humanin with 2 mL of bacteriostatic water and a 3 mg dose is 60 units on a U-100 syringe, about 3 doses per vial.

Vial
10 mg
Water
2 mL
Amount
3 mg

Draw to60 units

1 mL insulin syringe · 100 units

Mix it in the Reconstitution LabOpen the calculator

Run notes

Cycle
Weekly dosing typical. Limited human data — most run 8–12 week cycles cautiously.Community practice — opinions vary. Not a clinical recommendation.
Timing
Timing flexible. Weekly SubQ.
Route
SubQ injection
Stacks
MOTS-c, SS-31

Safety.

Common side effects

  • Injection site pain
  • Mild fatigue

Goes with.

Questions people ask.

What is Humanin?

Another mitochondrial-derived peptide. In cell and rodent studies it protects cells from programmed death, improves insulin sensitivity and lowers the toxicity of amyloid-beta, the protein linked to Alzheimer's.

How is Humanin dosed in research?

The research range for Humanin is 2–4 mg, weekly. Studied in research — not a recommendation.

How long does Humanin last?

The half-life of Humanin is unknown in humans.

What do people report on Humanin?

Commonly reported on Humanin: subtle or no felt effect, and community reports are sparse. Children of centenarians have higher humanin levels, but it has never been tested as a treatment in people.

Is Humanin safe?

The research basis for Humanin is emerging: primarily preclinical / limited human data. Common side effects in the library: injection site pain and mild fatigue.

What does Humanin stack with?

Common stacks for Humanin: MOTS-c and SS-31.

Research.

The literature

Search the latest research

Reference.

Cadence

Weekly

Half-life

Unknown in humans

Research basis

●●● Emerging

Primarily preclinical / limited human data

PepVault for iPhone

Track Humanin in PepVault

Log every dose and keep your vial and the doses left in it. 7 days free on the yearly plan for new subscribers.

Download on the App Store

Reviewed How we check the library